Want to join the conversation?
In 1Q16, $ESRX's network pharmacy revenue fell 8.7% versus 1Q15, mainly due to expected roll-off of some clients. Network generic fill rate grew to 85.9% of network claims. Home delivery and specialty revenue rose 10.2%, mainly due to inflation on branded drugs. Home delivery generic fill rate grew to 79.8% of home delivery claims in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?